Viewing Study NCT04848220


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2025-12-26 @ 3:16 AM
Study NCT ID: NCT04848220
Status: TERMINATED
Last Update Posted: 2023-12-12
First Post: 2021-04-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-05-20
Start Date Type: ACTUAL
Primary Completion Date: 2022-08-23
Primary Completion Date Type: ACTUAL
Completion Date: 2022-08-31
Completion Date Type: ACTUAL
First Submit Date: 2021-04-14
First Submit QC Date: None
Study First Post Date: 2021-04-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-08-18
Results First Submit QC Date: None
Results First Post Date: 2023-12-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-23
Last Update Post Date: 2023-12-12
Last Update Post Date Type: ACTUAL